When a dentist or physician decides to sell their practice, the initial decision process often begins and ends with valuation. Sellers want to know what multiple of earnings or collections the buyer is offering. But valuation is only a starting point.
The actual economic value of a transaction to the seller depends on how consideration is structured, how risk is allocated between the parties, and how post-closing compensation and governance terms are designed. In addition, if an earnout is contemplated, value will also depend upon the operational inputs the buyer brings to bear on the practice post-closing. For sellers who have spent years building clinical goodwill and operational value, understanding these structural elements is essential to making an informed decision.
How purchase consideration is structured
Most practice transactions divide total consideration into three components: cash at closing, rollover equity, and earnout payments.
Cash at closing
Cash at closing remains the most certain portion of value and typically represents the portion least subject to post-closing variables. However, its proportion relative to total consideration can vary significantly depending on the transaction structure. Recently, our firm has seen a trend of buyers utilizing “cashless” acquisition structures, where a significant portion of the purchase consideration is deferred or equity-based rather than paid in cash at closing. These arrangements can alter both the risk profile and the timing of a seller’s economic return.
Rollover equity
Rollover equity allows sellers to retain an ownership interest in the acquiring platform. In many cases, this feature is designed to align incentives between selling providers and the broader organization, allowing physicians and dentists to participate in future growth and a potential second liquidity event. The true value of rollover equity depends on a range of factors, including governance rights, dilution protections, capital structure, and the timing, terms and possibility of any future exit. Even with well-negotiated protections, sellers should be aware that the realization of value from rollover equity is also dependent upon market conditions.
Earnouts
Earnouts are contingent payments made to the seller after closing, typically conditioned on the practice achieving specified financial benchmarks during a defined measurement period. In other words, an earnout is a portion of the purchase price that the seller only receives if certain performance targets (e.g., revenue thresholds and EBITDA levels) are met following the transaction. Earnouts are commonly used to bridge valuation expectations between buyers and sellers and to align post-closing incentives. While earnouts can be an effective tool, they must be meticulously structured. Attention to items such as regulatory compliance, how performance is measured, how operational decisions impact results, and how post-closing integration affects underlying assumptions, become critical in ensuring the earnout is both compliant with applicable law and structured to deliver its intended value.
Tax implications of transaction structure
How a transaction is structured can have a meaningful impact on the seller’s after-tax proceeds. The distinction between an asset sale and an equity sale can materially affect tax treatment for both buyers and sellers.
Asset transactions are often preferred by buyers as they allow buyers to obtain a stepped-up tax basis in acquired assets. Conversely, asset transactions may result in varying tax consequences for sellers depending on how the purchase price is allocated. In an asset deal, the allocation of purchase price among asset categories (such as goodwill, tangible assets, and covenants not to compete) determines how proceeds are characterized for tax purposes.
Purchase price allocation directly affects whether a seller’s proceeds are taxed as ordinary income, capital gains, or self-employment income, each carrying different effective tax rates.
Equity transactions provide for different tax efficiencies and liability considerations, making early structural analysis particularly important. Similarly, the form of consideration (cash, equity rollover, or deferred earnout payments) may affect the timing and character of taxable events.
Sellers should work with qualified tax advisors early in the process to understand how structural decisions influence net economic value, rather than evaluating deal value solely on its pre-tax headline figure.
Post-closing compensation
For dentists and physicians who remain with the practice after closing, compensation structures frequently evolve to reflect the new operating model.
In addition to either a base salary or compensation tied solely to individual production or collections, compensation may include:
- bonuses based upon productivity benchmarks
- platform or management fee allocations
- integration or performance-based adjustments
In some transactions, buyers shift from individually based compensation models (where a provider’s pay is tied directly to his or her personal production) to a practice-level pool arrangement, in which compensation is derived from the collective performance of the clinic or group.
These structures are designed to create consistency and scalability across larger platforms. The specific formulas and definitions matter significantly and should be clearly documented and reviewed by counsel to avoid ambiguity.
In well-structured transactions, compensation frameworks are transparent, objective, and aligned with both clinical incentives and operational performance. In less clear arrangements, differences between expected and actual compensation can emerge over time, particularly where formulas are subject to interpretation or adjustment, which often results in disputes or a strained business relationship.
Regulatory and compliance considerations
Practice transactions in dentistry and medicine operate within established regulatory frameworks, including state corporate practice doctrines, fee-splitting restrictions, and federal healthcare regulations such as the Anti-Kickback Statute and Stark Law, where applicable.
These rules are an important part of deal structuring. They may influence how compensation is structured, how ownership interests are allocated, and how post-closing incentives are designed.
Well-advised transactions are structured to comply with applicable requirements while still achieving economic and operational objectives. The key is ensuring that financial and clinical incentives are appropriately aligned within those constraints.
Why timing matters
One of the most important aspects of negotiating any practice transaction is timing. Material business issues should be negotiated and reflected in the letter of intent and not left for negotiation during the definitive documents stage. Once exclusivity is in place, a seller’s flexibility to modify economic or structural terms is often reduced.
Engaging experienced counsel early in the process helps ensure that the structure reflects both the financial intent of the parties and the operational realities of the post-closing environment.
Close the deal with confidence
No two practice transactions are identical, even when headline valuations appear similar. The real driver of value is how risk, control, and economics are allocated across cash, equity, and post-closing performance. A well-structured deal is not about favoring one side, it is about ensuring that expectations are clearly defined, appropriately balanced, and executable in practice.